Public offerings often lead to short-term price declines due to the dilution of existing shares. However, the capital raised can be very beneficial for the company's long-term growth, depending on how it's utilized. For BBIO, this move suggests a focus on expanding its operations or funding further research and development, which could be positive in the long run.